TY  - JOUR
TI  - Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome
AB  - Metabolic syndrome is associated with a group of conditions abdominal obesity, high triglyceride levels, reduction in low-density lipoprotein, increased blood pressure, and increased fasting blood glucose. Hence, it poses a risk for type 2 diabetes and cardiovascular diseases. The prevalence of metabolic syndrome increases with age. Nesfatin-1, which affects different systems, has recently been discovered as a regulatory peptide molecule. With the discovery of nesfatin-1, it has been reported to inhibit the intake of nutrients and have significant regulatory effects on energy metabolism. As nesfatin-1 is present in both central and peripheral tissues, it is thought to have many functions. In addition to its suppressive effect on food intake, nesfatin-1 has also been reported to have an effect on the blood glucose level for regulating cardiac functions and affecting obesity by providing weight loss. Considering the effects of nesfatin-1, it may be associated with metabolic syndrome.
AU  - ÇİÇEK, Betül
AU  - konyalıgil, nurefşan
AU  - tekin, tuba
DO  - 10.5152/eurasianjmed.2019.18420
PY  - 2019
JO  - Eurasian Journal of Medicine
VL  - 51
IS  - 3
SN  - 1308-8734
SP  - 280
EP  - 284
DB  - TRDizin
UR  - http://search/yayin/detay/333853
ER  -